English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/123910
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Inhibitory effects of sigma-2 receptor agonists on T lymphocyte activation

AuthorsÍñiguez, Miguel Ángel ; Punzón, Carmen ; Nieto, Raquel ; Burgueño, Javier; Vela, Jose María; Fresno, Manuel
Issue Date13-Mar-2013
PublisherFrontiers Media
CitationFrontiers in Pharmacology 4: 1- 12 (2013)
AbstractSigma (s) receptor ligands are essentially known for their effects on the nervous system although recent studies have shown their potential effects modulating some other pathophysiological processes as cell proliferation, cancer, and the immune response. Here, we have analyzed the actions of s-1 and s-2 receptors ligands on T cell activation. Our results show that treatment of Jurkat T cells with s-2 agonists decreased the induction of the expression of Interleukin (IL)-2,Tumor necrosis factor (TNF)-a, and Cyclooxygenase (COX)-2 by activated T cells in a dose-dependent manner. These effects take place at the transcriptional level since s-2 agonists BD-737 and CB-184 diminished the activity of the promoters of those genes. Those immunosuppressive effects could be attributable to interference with transcription factor activation. Induced transcription mediated by Nuclear factor (NF)-kB or Nuclear Factor of Activated T cells (NFAT) was inhibited by s-2 agonists. These effects seem to be specific for s-2 agonists as no significant effects onT cell activation by s-1 ligands PRE-084 and BD-1063 were found. Our results provide new insights into the immunomodulatory actions of sligands and describe a new property of s-2 agonists, through inhibition of activation of transcription factors as NFAT by which these compounds are regulating gene expression. This may have important consequences on the possible therapeutic use of those compounds.
URIhttp://hdl.handle.net/10261/123910
DOI10.3389/fphar.2013.00023
Identifiersdoi: 10.3389/fphar.2013.00023
issn: 1663-9812
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
M_Fresno_Inhibitory_effects.pdf821,43 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.